<p>GRADE profile evidence of the included studies for pemetrexed VS bevacizumab.</p
<p>Volpara Density Grade (VDG) versus BI-RADS density score from a breast radiologist.</p
<p>Meta-analysis of the log hazard ratios of progression free survival comparing bevacizumab and sta...
Studies that identified factors differentiated by evidence type and quality scores.</p
<p>Evidence profile for Aspirin and Clopidogrel on the risk of vascular events.</p
<p>Comparison of primary outcomes for bevacizumab versus other angiogenesis inhibitors.</p
<p>CTCAE grade at the 12<sup>th</sup> course was significantly higher in the PTX+BEV group (n = 19) ...
<p>Summary of high-quality non-randomized studies comparing ranibizumab with bevacizumab.</p
<p>Characteristics of head-to-head studies comparing ranibizumab with bevacizumab (direct comparison...
<p>Summary of Evidence Reviewed Categorized by Inflammatory and Antiviral Outcomes.</p
Profile of individuals with CVD along with type and severity of CVD based on CAD threshold and gradi...
<p>Meta-analysis of the risk ratios of overall response rate comparing bevacizumab and standard ther...
Summary of DLS result of Bevacizumab at different storage conditions (trial 2).</p
<p>Clinical profiles of the healthy subjects and ESRD patients enrolled in this study.</p
<p>Grade profile for subcutaneous vs. submuscular for cubital tunnel syndrome.</p
Comparing baseline characteristics of study participants by antiretroviral therapy status.</p
<p>Volpara Density Grade (VDG) versus BI-RADS density score from a breast radiologist.</p
<p>Meta-analysis of the log hazard ratios of progression free survival comparing bevacizumab and sta...
Studies that identified factors differentiated by evidence type and quality scores.</p
<p>Evidence profile for Aspirin and Clopidogrel on the risk of vascular events.</p
<p>Comparison of primary outcomes for bevacizumab versus other angiogenesis inhibitors.</p
<p>CTCAE grade at the 12<sup>th</sup> course was significantly higher in the PTX+BEV group (n = 19) ...
<p>Summary of high-quality non-randomized studies comparing ranibizumab with bevacizumab.</p
<p>Characteristics of head-to-head studies comparing ranibizumab with bevacizumab (direct comparison...
<p>Summary of Evidence Reviewed Categorized by Inflammatory and Antiviral Outcomes.</p
Profile of individuals with CVD along with type and severity of CVD based on CAD threshold and gradi...
<p>Meta-analysis of the risk ratios of overall response rate comparing bevacizumab and standard ther...
Summary of DLS result of Bevacizumab at different storage conditions (trial 2).</p
<p>Clinical profiles of the healthy subjects and ESRD patients enrolled in this study.</p
<p>Grade profile for subcutaneous vs. submuscular for cubital tunnel syndrome.</p
Comparing baseline characteristics of study participants by antiretroviral therapy status.</p
<p>Volpara Density Grade (VDG) versus BI-RADS density score from a breast radiologist.</p
<p>Meta-analysis of the log hazard ratios of progression free survival comparing bevacizumab and sta...
Studies that identified factors differentiated by evidence type and quality scores.</p
DOI
Add to ORKG